⌘K

Login Start Free

Home/Filings/4/0001415889-24-000883

4//SEC Filing

Longpre Lara 4

Accession 0001415889-24-000883

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 8:25 PM ET

Size

4.8 KB

Accession

0001415889-24-000883

Insider Transaction Report

Form 4

Period: 2024-01-08

Mirum Pharmaceuticals, Inc.MIRM

Chief Development Officer

Transactions

Sale
Common Stock
2024-01-08$28.04/sh−1,019$28,568→ 105,254 total

Footnotes (1)

[F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Documents

1 file

4
form4-01102024_010122.xmlPrimary

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780347

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 8:25 PM ET
Size: 4.8 KB

View on SEC.gov